Approvals/TGA/IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Approved

STANDARD

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Accord Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1dd58cd2fb363c4b
Product Name: IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Artg Id: 209856
Artg Name: IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor: Accord Healthcare Pty Ltd
Company Detail Path: /organization/accord-healthcare-pty-ltd
Artg Date: 2014-06-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02606-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02604-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1dd58cd2fb363c4b

Type

Standard